We use tools, such as cookies, to enable essential services and functionality on our site. We also use this to collect data on how our visitors interact with our site, products and services. By clicking accept, you agree to our use of these tools for advertising, analytics and support. I Accept Privacy Policy Cookie Policy

immunodiagnosticsystems
0
immunodiagnosticsystems
0
  • About IDS
    • Company Overview
    • Corporate History
    • Strategic Vision
    • Board of Directors
    • IDS Worldwide
    • IDS Values
    • Careers
    • News and Events
  • Products
    Automated
    Manual
  • Instrumentation
    • IDS-iSYS Multi-Discipline Automated System
    • Specifications
    • Service & Support
  • Clinical Areas
    Bone Metabolism
    Calcium Metabolism
    CKD-MBD
    Growth
    Cartilage Markers
    Reproductive
    Autoimmunity
    Infectious Diseases
    Allergy
    Covid-19
    Sarcoidosis Assays
    Therapeutic Drug Monitoring
    Endocrine Hypertension
    Adrenal Function
  • Research Areas
    Animal Research
    Bone Turnover Markers
    Other Research Areas
  • COVID-19 Tests
  • Investor Relations
  • Contact
immunodiagnosticsystems
+44 (0)191 5190660
0

Quotes

  • About IDS
    • Company Overview
    • Corporate History
    • Strategic Vision
    • Board of Directors
    • IDS Worldwide
    • IDS Values
    • Careers
    • News and Events
  • Products
    Automated
    Manual
  • Instrumentation
    • IDS-iSYS Multi-Discipline Automated System
    • Specifications
    • Service & Support
  • Clinical Areas
    Bone Metabolism
    Calcium Metabolism
    CKD-MBD
    Growth
    Cartilage Markers
    Reproductive
    Autoimmunity
    Infectious Diseases
    Allergy
    Covid-19
    Sarcoidosis Assays
    Therapeutic Drug Monitoring
    Endocrine Hypertension
    Adrenal Function
  • Research Areas
    Animal Research
    Bone Turnover Markers
    Other Research Areas
  • COVID-19 Tests
  • Investor Relations
  • Contact

Month: August 2015

  • All News
  • Company News
  • Event News
  • Industry News
  • Product News
IDS investor relations

Visit IDS at the IBMS 2015 ‐  Institute of Biomedical Science Congress (28th – 30th September); Birmingham, UK.

  Visit us at Stand #810 – Hall 3 to find out more about our specialty automated testing solutions and manual immunoassay portfolio. Hypertension Growth Bone Metabolism Calcium Metabolism We are expanding our automated immunoassay solutions for calcium metabolism, growth and hypertension disease areas: IDS‐iSYS and IDS‐iSYS² Multi‐discipline automated systems – The IDS‐iSYS family of fully‐automated analyzers […]

  • About Us
  • Products
  • Instrumentation
  • Clinical Areas
  • Research Areas
  • Investor Relations
  • Contact
Connect with us
Connect with us
Connect with us
  • Careers
  • News & Events
  • Sitemap
  • Cookie Policy
  • Terms of Use Policy
  • Privacy Policy
  • Acceptable Use Policy
  • Purchasing T&Cs
  • Terms of Sale
IDS PLC © 2021 Immunodiagnostic Systems. All Rights Reserved. IDS is a listed company, traded on the Alternative Investment Market (AIM; trading symbol IDH) of the London Stock Exchange. Please note our sites uses cookies for content personalisation, please review our cookie policy for further information.

To receive our Newsletter Document Name, please provide us with your following details:

To receive our Newsletter, please provide us with your following details: